You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 4, April 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (24)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Bipolar Disorder
 •Schizophrenia
 •Alert me on articles by topic

DNA Fragmentation Decreased in Schizophrenia but Not Bipolar Disorder

Francine M. Benes, MD, PhD; John Walsh, MA; Sujoy Bhattacharyya, MS; Archna Sheth; Sabina Berretta, MD

Arch Gen Psychiatry. 2003;60:359-364.

Background  Apoptosis is thought to play a role in neuronal pathology in schizophrenia and bipolar disorder.

Methods  To test this hypothesis, the Klenow method for in situ end-labeling of single-stranded DNA breaks was applied to anterior cingulate cortex from 18 healthy controls, 18 schizophrenic subjects, and 10 bipolar subjects.

Results  An unexpected reduction (71%) in Klenow-positive nuclei was found in schizophrenic but not in bipolar cortexes.

Conclusions  To our knowledge to date, this is the first demonstration that there is much less DNA fragmentation in individuals with schizophrenia than in healthy controls and bipolar subjects, which raises a key question as to whether this alteration represents an adaptive or nonadaptive change in the regulation of intracellular signaling and mitochondrial oxidative pathways associated with apoptosis.


From the Laboratories for Structural Neuroscience, McLean Hospital, Belmont, Mass, and the Program in Neuroscience and Department of Psychiatry, Harvard Medical School, Boston, Mass.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anatomical Abnormalities of the Anterior Cingulate Cortex in Schizophrenia: Bridging the Gap Between Neuroimaging and Neuropathology
Fornito et al.
Schizophr Bull 2008;0:sbn025v1-sbn025.
ABSTRACT | FULL TEXT  

Searching for Unique Endophenotypes for Schizophrenia and Bipolar Disorder Within Neural Circuits and Their Molecular Regulatory Mechanisms
Benes
Schizophr Bull 2007;33:932-936.
ABSTRACT | FULL TEXT  

Chromatin Alterations Associated With Down-regulated Metabolic Gene Expression in the Prefrontal Cortex of Subjects With Schizophrenia
Akbarian et al.
Arch Gen Psychiatry 2005;62:829-840.
ABSTRACT | FULL TEXT  

Density of Glutamic Acid Decarboxylase 67 Messenger RNA-Containing Neurons That Express the N-Methyl-D-Aspartate Receptor Subunit NR2A in the Anterior Cingulate Cortex in Schizophrenia and Bipolar Disorder
Woo et al.
Arch Gen Psychiatry 2004;61:649-657.
ABSTRACT | FULL TEXT  

Apoptotic Proteins in the Temporal Cortex in Schizophrenia: High Bax/Bcl-2 Ratio Without Caspase-3 Activation
Jarskog et al.
Am. J. Psychiatry 2004;161:109-115.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.